tRNA Modifications and Dysregulation: Implications for Brain Diseases. [PDF]
Lv X, Zhang R, Li S, Jin X.
europepmc +1 more source
ART. XV.—The Human Brain; its Structure, Physiology and Diseases, with a Description of the Typical Forms of Brain in the Animal Kingdom [PDF]
Samuel Solly
openalex +1 more source
Comparison of cell-fusing activity of brain suspensions from patients with Creutzfeldt-Jakob disease and other degenerative neurological diseases. [PDF]
Marie-Claude Moreau-Dubois+2 more
openalex +1 more source
ABSTRACT Introduction The kappa‐free light chain (κ‐FLC) index is known to be highly sensitive and specific for diagnosing multiple sclerosis (MS), while little is understood about lambda (λ)‐FLC. This study assessed the κ‐FLC and λ‐FLC indices in autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy.
Michael Levraut+11 more
wiley +1 more source
Identifying the quality markers and optimizing the processing of Gastrodiae rhizoma to treat brain diseases. [PDF]
Fu Y+8 more
europepmc +1 more source
Fatal Foam Cell Arteritis of the Brain After Irradiation for Hodgkin's Disease: Angiography and Pathology [PDF]
A. Robert Kagan+2 more
openalex +1 more source
Stage‐Dependent Inhibitory Connectivity in Striatal‐Motor Circuit in Huntington's Disease
ABSTRACT Background Elucidating dysfunctional connectivity patterns among key brain regions in Huntington's disease (HD) underlying progression may have implications for developing treatment and therapeutic evaluation. Objective Explore the relationship between abnormal spontaneous resting‐state activity and atrophy in HD‐specific brain regions and ...
Yinghua Jing+4 more
wiley +1 more source
Explainable Machine Learning Models for Brain Diseases: Insights from a Systematic Review. [PDF]
Rodríguez Mallma MJ+6 more
europepmc +1 more source
Acute Changes in Blood Pressure Following Vascular Diseases in the Brain Stem [PDF]
Akira Itô, Teruo Omae, S Katsuki
openalex +1 more source
Cognitive and Patient‐Reported Outcome Measures in LGI‐1‐IgG Autoimmune Encephalitis
ABSTRACT Objective Clinical outcome measures for autoimmune encephalitis (AE) are not yet well defined. Cognitive outcome measures (CogOs) and patient‐reported outcomes (PROs) may capture the symptoms of AE, beyond clinician‐reported outcomes (ClinROs) (the Modified Rankin Scale [mRS] and Clinical Assessment Scale in Autoimmune Encephalitis [CASE ...
Tatchaporn Ongphichetmetha+8 more
wiley +1 more source